QA: Rallybio Corp in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001739410_2024_Rallybio_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001739410, Rallybio Corp

  xvar xval
0 AssetsCurrent 114,789,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 246,000
3 remainder_Assets 585,000
4 LiabilitiesCurrent 9,263,000
5 LiabilitiesNoncurrent 173,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 25,388,000
9 ResearchAndDevelopmentExpense 53,544,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 4,368,000
13 remainder_ComprehensiveNetIncome 229,000
  yvar yval
0 Assets 115,620,000
1 Liabilities 9,436,000
2 Expenses 78,932,000
3 Revenues 0
4 StockholdersEquity 106,184,000
5 NetIncome -74,564,000
6 ComprehensiveNetIncome -74,449,500
7 BaseVar 104,292,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.51
9 EconomicCapitalRatio 3.36

Edgar->Model Mapping

Feature Distribution

Change over Time